key: cord-0812752-ujv69rde
authors: Tagarro, A.; Sanz-Santaeufemia, F.J.; Grasa, C.; Cobos, E.; Yebra, J.; Alonso-Cadenas, J.A.; Baquero-Artigao, F.; Mesa, Guzmán JM.; Perez, Seoane B.; Calvo, C.; Herreros, M.L.; Epalza, C.; Melendo, S.; Dominguez-Rodriguez, S.; Vidal, P.; Pacheco, M.; Ballesteros, A.; Bernardino, M.; Villanueva-Medina, S.; Rodríguez, Molino P.; Miragaya, Castro S.; Rivière, J.; Garcés, R.; Santiago, B.; Fumadó, V.; Urretavizcaya-Martínez, M.; García-García, M.L.; Penín, M.; Cava, F.; Sáez, E.; Iglesias-Bouzas, M.I.; Herrero, B.; Reinoso, T.; Moraleda, C.
title: Dynamics of RT-PCR and Serologic Test Results in Children with SARS-CoV-2 Infection
date: 2021-09-25
journal: J Pediatr
DOI: 10.1016/j.jpeds.2021.09.029
sha: c043db4157ae473c6de395e224523983f0080b4e
doc_id: 812752
cord_uid: ujv69rde

OBJECTIVES: To determine the time to RT-PCR negativity after the first positive RT-PCR test, factors associated with longer time to RT-PCR negativity, proportion of children seroconverting after proven SARS-CoV-2 infection, and factors associated with the lack of seroconversion. STUDY DESIGN: EPICO-AEP is a multicenter study conducted in Spanish children to assess the characteristics of COVID-19. In a subset of patients, three serial RT-PCR tests on nasopharyngeal swab specimens were performed after the first RT-PCR test, and IgG serology for SARS-CoV-2 antibodies was performed in the acute and follow up (<14 and ≥14 days after diagnosis) phase. RESULTS: In total, 324 patients were included in the study. Median [IQR] time to RT-PCR negativity was 17 [8–29] days, and 35% of patients remained positive >4 weeks after the first RT-PCR test. The probability of RT-PCR negativity did not differ across groups defined by sex, disease severity, immunosuppressive drugs, or clinical phenotype. Globally, 24% of children failed to seroconvert after infection. Seroconversion was associated with hospitalization, persistence of RT-PCR positivity and days of fever. CONCLUSIONS: Time to RT-PCR negativity was long, regardless of severity of symptoms or other patients’ features. This should be considered when interpreting RT-PCR results in a child with symptoms, especially those with mild symptoms. Seroprevalence and post-immunization studies should consider that one in four infected children fail to seroconvert.

To determine the time to RT-PCR negativity after the first positive RT-PCR test, factors associated with longer time to RT-PCR negativity, proportion of children seroconverting after proven SARS-CoV-2 infection, and factors associated with the lack of seroconversion. Study design. EPICO-AEP is a multicenter study conducted in Spanish children to assess the characteristics of COVID-19. In a subset of patients, three serial RT-PCR tests on nasopharyngeal swab specimens were performed after the first RT-PCR test, and IgG serology for SARS-CoV-2 antibodies was performed in the acute and follow up (<14 and ≥14 days after diagnosis) phase.

Results. In total, 324 patients were included in the study. Median [IQR] time to RT-PCR negativity was 17 days, and 35% of patients remained positive >4 weeks after the first RT-PCR test. The probability of RT-PCR negativity did not differ across groups defined by sex, disease severity, immunosuppressive drugs, or clinical phenotype. Globally, 24% of children failed to seroconvert after infection. Seroconversion was associated with hospitalization, persistence of RT-PCR positivity and days of fever.

Conclusions. Time to RT-PCR negativity was long, regardless of severity of symptoms or other patients' features. This should be considered when interpreting RT-PCR results in a child with symptoms, especially those with mild symptoms. Seroprevalence and post-immunization studies should consider that one in four infected children fail to seroconvert.

Studies of serial respiratory viral load and serum antibody responses from children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are limited. [1] SARS-CoV-2 detection by reverse transcription-polymerase chain reaction (RT-PCR) testing of respiratory samples is widely used to diagnose and monitor infection. A better understanding of the dynamics of RT-PCR and serological testing in children with SarsS-CoV-2 infection (coronavirus disease 2019 (COVID-19)) may help inform health care decisions, including quarantine strategies and duration.

The severity and progression of SARS-CoV-2 infection has multifactorial associations including host immunity, and an adequate antibody response might confer protection to future SARS-CoV-2 infection. The dynamics of the antibody response has been well described in adults, [2] . Studies of multisystem inflammatory syndrome in children (MIS-C) suggest that not all patients develop detectable antibodies despite a strong dysregulated immune response. [3] Knowing the proportion of children who do not develop a detectable antibody response and the factors related to the absence of seroconversion might be useful for the diagnosis of post-COVID-19 conditions and reinfections.

The aims of the present study were to determine the time to RT-PCR negativity after the first positive RT-PCR test result, to investigate factors associated with a delayed RT-PCR negative result, to assess the rate of seroconversion after proven SARS-CoV-2 infection, and to examine the factors associated with the absence of seroconversion. 

Respiratory samples were obtained from nasopharyngeal swabs. RT-PCR was performed according to standardized techniques at each center. RT-PCR was considered positive according to the limits J o u r n a l P r e -p r o o f provided by the manufacturers. For analysis purposes (Figure 3 ), negative was considered as 45 cycle thresholds (Ct). In all centers, IgG antibodies against the SARS-CoV-2 surface S1 domain of the spike protein or against the internal nucleocapsid protein were measured in EDTA-plasma samples using standardized commercial techniques.

An electronic case report form was built, and the responsible physician of each center completed the form with clinical data and laboratory test results. Data included age, sex, comorbidities, immunosuppressant medication, date of diagnosis, syndromic diagnosis, and serial RT-PCR and serology test results.

Baseline characteristics were described using frequencies for categorical variables and medians (interquartile range [IQR]) for continuous variables, both in the total population and after stratification based on RT-PCR test result. Chi-square or Fisher exact test (<5 frequencies) was applied to assess differences across groups for categorical variables, and the Mann-Whitney test was used for continuous variables.

For time-to-event analysis, the time to RT-PCR negativity was analyzed employing Kaplan-Meier estimates according to sociodemographic and clinical variables including sex, age, days of fever, diagnostic syndrome and severity, and the log-rank test was used for comparison of curves.

The time to RT-PCR negativity and association with potential risk factors was assessed using a generalized multivariable linear model. Variable selection for the model was performed through the stepwise Akaike Information Criterion. Two-tabled P-values were considered significant when p<0.05.

LOESS smoothing splines were fitted to the Ct curves to plot the dynamics of extinct viral load along time to follow up. For this plot, a Ct of 45 was considered as negative/undetectable. R software was used for all analyses (R Development Core Team, 2009).

A total of 324 children from 50 centers were included in the present study and followed for a median of 20 days [IQR, 13 to 32, range 0 to 120 days]. The median age was 4.5 years [IQR, 0.6-11.6], 188 (58%) children were male, and the median days of fever at diagnosis was 2 [IQR, [0] [1] [2] [3] [4] Cox multivariable analysis was performed to investigate whether confounding might have attenuated the suggested association with severity of disease. The covariates included in the raw model were sex, phenotype, age, days of fever, and severity. However, according to the backward stepwise selection method, only sex was selected to be included in the final best fitting model (coef. 0.85 (95% CI 0.66-1.1), P value = .229). We did not find any factor influencing the probability of achieving a negative RT-PCR test result. There were no differences between patients who achieved or did not achieve negativity during the follow up period by sex, age, days of fever at diagnosis, clinical phenotype at presentation, immunosuppressive medication, hospitalization or need for PICU admission or high-flow oxygen therapy.

The We compared the 27 children who seroconverted with the 22 who did not (Table) . We 

In our study, after diagnosis with clinical symptoms, the median time to RT-PCR test negativity in children with SARS-Cov-2 infection was 17 days, irrespective of the type or severity of presenting features, and 35% of children remained RT-PCR positive more for more than one month after the first positive RT-PCR. We also showed that at least 25% of patients did not develop SARS-CoV-2 IgG antibodies after confirmed infection, particularly those not hospitalized and those with early SARS-CoV-2 RT-PCR clearance.

Time to RT-PCT negativity did not differ by sex, disease severity, receipt of immunosuppressive drugs, or clinical phenotype. Kaplan-Meier analysis indicated a trend for patients admitted to the PICU remain positive for a slightly longer time than others, but the confidence intervals overlapped, and the p-value was not significant.

In adults with SARS-CoV-2 infection, RT-PCR positivity can persist for weeks after the resolution of symptoms; however, the median time to RT-PCR negativity is unclear. Some studies have reported a median time from 12 to 35 days, but there is large variability depending on age, the severity of the disease and the sample type. [4, 5] In a study of 68 children, patients in the 0-through 5-year age group had a median of 22 days to RT-PCR negativity, and patients aged 6 through 15 years had a median of 32 days, compared with 18 days for patients 16 to 22 years of age. [6] In our study, children seemed to have more rapid clearance than adults, which might be related to the high median Ct observed (38 [IQR, 35.5 to 40]) indicating low viral load. In adults, the median initial Ct value has been reported to be 28 (95% confidence interval: 27-28). [7] Our results are consistent with similar studies in children conducted with smaller sample sizes. A Korean study reporting 71 symptomatic children showed a median time to negativity of 17.6 days; [1] a study from Singapore observed a median time of 16 days; [8] and a study of 68 children from the US reported median duration of viral shedding (RT-PCR positivity) of 19.5 days (IQR = 12-39). [6] J o u r n a l P r e -p r o o f However, it is important to consider that a proportion of patients in our study remained positive for more than 21 days after diagnosis. Consistent with our findings, it has been described that 19% of people continue to show nasopharyngeal RT-PCR positivity 2 or more weeks after the resolution of symptoms. [9] Likewise, in an Italian study, 28/191 (14.7%) adults with a mean (IQR) age of 51 years (41-59), were persistently positive between day 41 and 60 after discharge. [5] Prolonged or recurrent viral RNA detection from the nasopharynx does not necessarily indicate prolonged viral infectiousness. Isolation of infectious viruses from upper respiratory specimens more than 10 days after the onset of illness has only rarely been documented in patients who had a non-severe infection and whose symptoms had resolved. [10] Rather, our findings should be used to better Serologic tests play an important role in the clinical diagnosis of post infectious or late-stage patients with SARS-VoV-2 related conditions. Our data suggest that negative SARS-CoV-2 serologic test results alone do not exclude previous SARS-CoV-2 in children. In a previous study, only one-half of the patients demonstrated adequate neutralizing antibodies during the time frame of specimen collection. [6] This is important consideration when considering post infectious complications such as MIS-C. Interestingly, patients with mild disease and shorter time to RT-PCR negativity in our study seroconverted less often than patients with more severe disease and who had more prolonged RT-PCR positivity, suggesting that the level and persistence of viral material may be key to developing antibodies. These findings also suggest that detectable antibodies by routine techniques are not a useful marker for clinical SARS-CoV-2 infection. By contrast, the absence of detectable antibodies J o u r n a l P r e -p r o o f may be related to early clearance, mild disease and, possibly, a good innate response. We also should consider that some patients may not have initiated seroconversion at the time of the second test. Median time from RT-PCR positivity as studied by to seropositivity, by chemiluminescent testing, has been reported to be 18 days in children. [6] Our data also should be considered for interpretation of seroprevalence studies, especially in children, who usually have mild disease seem to achieve PCR negativity earlier than adults and may remain seronegative.

Almost all adults seroconvert after confirmed COVID-19. [9] However, the sensitivity of ELISA tests targeting the nucleocapsid or spike protein, or both (combined) antigens is 0.79 (95%CI 0.68-0.88), 0.80 (95%CI 0.62-0.92), and 0.86 (85%CI 0.68-0.91), respectively. [4] From our data, we cannot state definitively whether the proportion of children who did not seroconvert did not develop a humoral response, or if the ELISA techniques were unable to detect the antibodies.

The strengths of our study include a large sample size, serial testing, and a multicenter approach. Our study has several limitations. As a multicenter study, the techniques used for virus detection and antibody assays were not uniform. Also, we did not analyze neutralizing antibodies or the cross-reactivity of serology tests for SARS-CoV-2, although the specificity of ELISA and CLIA ranges from 92% to 100%. [4] Due to the exceptional situation, mainly during the first months of the pandemic, several patients were lost to follow up, and there was some variability in the timing between tests. Ct information was available for a proportion of participants only, so the analysis related to Ct should be interpreted with caution. Reporting Ct values as a tool for assessing with exactitude the viral load has been challenged. [11, 12] However, other reports have reported a good correlation between Ct value and viral loads in samples obtained from children with SARS-CoV-2 infection (r = -1), with lower values of viral loads in asymptomatic children and children aged >1 year. [13] Some centers are reporting Ct values after normalization or in a semiquantitative format and, in practice, most centers use CT as a proxy for high or low viral load. 

Pediatric Infectious Diseases Unit. Department of Pediatrics

Pediatric Intensive Care Unit

*List of additional members of the EPICO-AEP Working Group is available at www.jpeds.com (Appendix)

Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Multiinflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain

Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals

Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients

Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19

SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children

Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study

Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load

Challenges and Controversies to Testing for COVID-19

Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection

Additional members of the EPICO-AEP Working Group: Teresa del Rosal

María Méndez (Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Spain), Ángela Hurtado (Instituto Hispalense de Pediatría, Spain)

María Sánchez-Códez

Zulema Lobato (Althaia

Itziar Astigarraga, Olatz Villate

Elena Díaz J o u r n a l P r e -p r o o f (Hospital

Miguel Lafuente, Matilde Bustillo (Hospital Infantil de

Nerea Domínguez-Pinilla (Hospital Virgen de la Salud, Spain)

Marta Osuna (Hospital HM Montepríncipe, Spain)

Noelia Berciano Jiménez (Hospital

We thank all the patients and families for their participation in the study, and the laboratory staff and clinical staff members who cared for them. We thank Kenneth McCreath for the meaningful comments and suggestions on English writing. K.M. is a medical English consultant funded by Universidad Europea de Madrid.